Abstract:Background: Phthalate exposure was reported to induce defects in ovarian function, and further influence embryo development and pregnancy outcomes. However, the data about the associations of phthalates with intermediate and pregnancy outcomes of in vitro fertilization (IVF) cycles are scarce in the Chinese population. Methods: A total of 663 women receiving IVF/intracytoplasmic sperm injection (ICSI) treatments in our center were enrolled in this analysis. They provided one urine sample on the day of oocyte retrieval. We measured urinary concentrations of eight phthalate metabolites. Generalized linear models were used to analyze the associations of urinary phthalate metabolites with ovarian response, fertilization, early embryo development, and pregnancy outcomes. Results: Among all the phthalate metabolites, mono-n-butyl phthalate (MBP) had the highest urinary concentration with a median level of 101.51 mu g/g creatinine (Cr). MBP concentration was inversely associated with normal fertilization odds (overall P-trend < 0.01). There was a significant correlation of monoethyl phthalate (MEP) with decreased odds of normal fertilization in medium-concentration group compared to low-concentration group (overall P-trend = 0.02). No significant associations of metabolite concentrations with the odds of good-quality embryos on day 3 or blastocyst formation were found. Monomethyl phthalate (MMP) and MEP in medium-concentration group reduced 22.4% (95% CI: 0.64-0.94, overall P-trend = 0.04) and 21.9% (95% CI: 0.64-0.95, overall P-trend = 0.05) of the odds to gain good-quality blastocyst compared to low-concentration group. The eight phthalate metabolites were not correlated to clinical pregnancy rate, live birth rate, or early miscarriage rate. There was no significant association of di (2-ethylhexyl) phthalate (DEHP) metabolites observed with any clinical outcomes in the total population. After excluding male infertility, mono (2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) in medium-concentration group turned to be associated with a higher number of retrieved oocytes (overall P-trend = 0.04), whereas mono (2-ethyl-5-oxohexyl) phthalate (MEOHP) in medium-concentration group was associated with a lower odds of normal fertilization compared to low-concentration group (overall P-trend = 0.02). Conclusions: Urinary MBP concentration was much higher compared to other phthalate metabolites in this cohort of Chinese IVF/ICSI women, and also higher than it was reported by studies in other countries. MBP showed adverse impacts on fertilization. MMP and MEP could affect blastocyst quality, but not embryo quality on day 3. DEHP metabolites didn't show consistent reproductive toxicities as demonstrated in previous studies.

Phthalate metabolites and biomarkers of oxidative stress in the follicular fluid of women undergoing in vitro fertilization

Follicular Fluid Concentrations of Phthalate Metabolites Are Associated with Altered Intrafollicular Reproductive Hormones in Women Undergoing in Vitro Fertilization

Associations Between Phthalate Metabolites and Cytokines in the Follicular Fluid of Women Undergoing in Vitro Fertilization.

Follicular Fluid and Urinary Concentrations of Phthalate Metabolites among Infertile Women and Associations with in Vitro Fertilization Parameters

Associations Between Phthalate Metabolite Concentrations in Follicular Fluid and Reproductive Outcomes among Women Undergoing in Vitro Fertilization/Intracytoplasmic Sperm Injection Treatment.

Associations between medication use and phthalate metabolites in urine and follicular fluid among women undergoing in vitro fertilization

Predictors of Phthalate Metabolites in Urine and Follicular Fluid and Correlations Between Urine and Follicular Fluid Phthalate Metabolite Concentrations among Women Undergoing in Vitro Fertilization.

Associations Betweenphthalatemetaboliteconcentrationsinfollicularfluidand Reproductive OutcomesamongWomenUndergoing in Vitro Fertilization/ Intracytoplasmic SpermInjectionTreatment

Associations between urinary phthalate concentrations and antral follicle count among women undergoing in vitro fertilization

Relationship between phthalates exposure, risk of decreased ovarian reserve, and oxidative stress levels

Urinary Concentrations Of Phthalates In Couples Planning Pregnancy And Its Association With 8-Hydroxy-2 '-Deoxyguanosine, A Biomarker Of Oxidative Stress: Longitudinal Investigation Of Fertility And The Environment Study

The Associations of Urinary Phthalate Metabolites with the Intermediate and Pregnancy Outcomes of Women Receiving IVF/ICSI Treatments: A Prospective Single-Center Study.

The association of serum phthalate metabolites with biomarkers of ovarian reserve in women of childbearing age

Phthalate metabolites in urine and follicular fluid in relation to menstrual cycle characteristics in women seeking fertility assistance

Urinary phthalate metabolites are associated with biomarkers of DNA damage and lipid peroxidation in pregnant women – Tainan Birth Cohort Study (TBCS)

Maternal preconception phthalate metabolite concentrations in follicular fluid and neonatal birth weight conceived by women undergoing in vitro fertilization

Urinary Phthalate Metabolites in Relation to Serum Anti-Müllerian Hormone and Inhibin B Levels among Women from a Fertility Center: a Retrospective Analysis

Gender associations between phthalate exposure and biomarkers of oxidative stress: A prospective cohort study

Association between Diethylhexyl Phthalate Exposure with Folliculogenesis and Ovarian Steroidogenesis: A Systematic Review and Meta-Analysis

Dysregulation of Steroid Metabolome in Follicular Fluid Links Phthalate Exposure to Diminished Ovarian Reserve of Childbearing-Age Women

Phthalate and DINCH exposure and ovarian reserve markers among women seeking infertility care